Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Pfizer cans twice-daily oral obesity program after half of patients leave trial while once daily continues
Fierce Biotech
Fri, 12/1/23 - 09:50 am
Pfizer
obesity
clinical trials
danuglipron
Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News
BioSpace
Fri, 12/1/23 - 09:46 am
Altimmune
clinical trials
obesity
GLP-1 agonist
pemvidutide
Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters
BioSpace
Mon, 11/20/23 - 10:07 am
Carmot Therapeutics
obesity
IPOs
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Fri, 11/17/23 - 10:02 am
Lonza
drug manufacturing
obesity
Novo Nordisk
Eli Lilly
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Wed, 11/15/23 - 12:04 pm
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Fri, 11/10/23 - 10:11 am
Novo Nordisk
diabetes
obesity
drug manufacturing
AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug
Fierce Biotech
Thu, 11/9/23 - 09:58 am
AstraZeneca
obesity
sickle cell disease
Eccogene
earnings
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
BioPharma Dive
Tue, 11/7/23 - 09:50 am
OrsoBio
Eli Lilly
funding
obesity
diabetes
'This field is in its infancy': Amgen noncommittal on oral obesity med until phase 1 data arrive
Fierce Biotech
Wed, 11/1/23 - 10:17 am
Amgen
obesity
AMG-786
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Stat
Thu, 10/26/23 - 11:24 am
Pfizer
danuglipron
obesity
Wegovy
Mounjaro
Novo Nordisk
GE HealthCare, Novo Nordisk partner to treat diabetes and obesity with ultrasound
Mass Device
Fri, 10/20/23 - 10:14 am
Medtech
GE Healthcare
Novo Nordisk
PFUS
ultrasound
obesity
type 2 diabetes
Eli Lilly plans diabetes drug trial for kids as young as 6 years - Bloomberg
Yahoo/Reuters
Fri, 10/20/23 - 10:02 am
Eli Lilly
Mounjaro
obesity
pediatric
clinical trials
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Fri, 10/6/23 - 10:01 am
Boehringer Ingelheim
Zealand Pharma
clinical trials
obesity
survodutide
Structure Therapeutics surges on promising early stage obesity drug data
Reuters
Fri, 09/29/23 - 10:21 am
Structure Therapeutics
obesity
weight loss
clinical trials
GSBR-1290
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Yahoo/Bloomberg
Sun, 09/24/23 - 08:56 pm
Novo Nordisk
Ozempic
Wegovy
obesity
weight loss
Altimmune completes dosing in MOMENTUM trial to treat obesity
Clinical Trials Arena
Wed, 09/13/23 - 11:15 am
Altimmune
clinical trials
pemvidutide
obesity
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
Mon, 09/11/23 - 12:26 pm
Novo Nordisk
Eli Lilly
GLP-1 agonist
obesity
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Thu, 09/7/23 - 10:12 am
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
Novo Nordisk launches Wegovy for obese patients in UK
Pharmaceutical Business Review
Tue, 09/5/23 - 11:25 am
Novo Nordisk
UK
Wegovy
obesity
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Motley Fool
Tue, 09/5/23 - 11:23 am
Eli Lilly
Alzheimer's disease
obesity
painkillers
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »